The ForeseeHome was FDA approved for monitoring eyes with dry age-related macular degeneration (AMD). NJRetina was involved in the early studies regarding this device for early detection of conversion from dry to wet AMD. Large clinical trials have shown that eyes treated earlier in the course of disease have better visual outcomes.
Howard Fine discusses the ForeseeHome device which was FDA approved in 2010
Bookmark the permalink.